Multi-Hospital Eastern Atlantic Restenosis Trial II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty (Q67904457)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 November 1991

Language	Label	Description	Also known as
English	Multi-Hospital Eastern Atlantic Restenosis Trial II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty	scientific article published on 01 November 1991

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835276%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Multi-Hospital Eastern Atlantic Restenosis Trial. II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835276%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Multi-Hospital Eastern Atlantic Restenosis Trial II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty (English)

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

coronary balloon angioplasty

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835276

6 December 2022

Cardiology and cardiovascular medicine

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

author name string

M. P. Savage

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835276

6 December 2022

S. Goldberg

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835276

6 December 2022

R. G. Macdonald

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835276

6 December 2022

T. A. Bass

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835276

6 December 2022

J. R. Margolis

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835276

6 December 2022

H. B. Whitworth

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835276

6 December 2022

A. S. Taussig

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835276

6 December 2022

G. Vetrovec

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835276

6 December 2022

M. Cowley

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835276

6 December 2022

A. A. Bove

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835276

6 December 2022

language of work or name

0 references

publication date

1 November 1991

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835276%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

full work available at URL

https://api.elsevier.com/content/article/PII:000287039190561U?httpAccept=text/xml

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

https://api.elsevier.com/content/article/PII:000287039190561U?httpAccept=text/plain

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

American Heart Journal

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835276%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

122

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835276%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835276%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1239-1244

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835276%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood institute

1

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Restenosis after successful coronary angioplasty in patients with single-vessel disease

2

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group

3

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Multi-Hospital Eastern Atlantic Restenosis Trial: design, recruitment, and feasibility. M-HEART Investigators

4

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Medical approaches to prevention of restenosis after coronary angioplasty

5

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Restenosis following coronary angioplasty

6

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model

7

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Deep arterial injury during experimental angioplasty: Relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis

8

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Platelet accumulation in experimental angioplasty: time course and relation to vascular injury

9

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

The pathogenesis of atherosclerosis (first of two parts)

10

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

The pathogenesis of atherosclerosis (second of two parts)

11

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

The pathogenesis of atherosclerosis--an update

12

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Effect of antiplatelet therapy on restenosis after experimental angioplasty

13

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty

14

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty

16

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Estimation of the effects of angioplasty on coronary stenosis using quantitative video angiography.

18

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Restenosis after arterial angioplasty: A hemorrheologic response to injury

19

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty

20

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Restenosis after successful coronary angioplasty. Pathophysiology and prevention

21

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Reduction in myocardial neutrophil accumulation and infarct size following administration of thromboxane inhibitor U-63,557A.

23

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Receptor-mediated mitogenic effect of thromboxane A2 in vascular smooth muscle cells

24

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty

25

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug

26

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Antiaggregatory effects of thromboxane receptor antagonists in vivo

27

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

BM 13.177, A SELECTIVE BLOCKER OF PLATELET AND VESSEL WALL THROMBOXANE RECEPTORS, IS ACTIVE IN MAN

28

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

The pharmacokinetic and pharmacodynamic profiles of the thromboxane A-2 receptor blocker BM 13.177

29

1 reference

10.1016/0002-8703(91)90561-U

https://api.crossref.org/works/10.1016/0002-8703(91)90561-U

6 December 2022

Identifiers

10.1016/0002-8703(91)90561-U

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835276%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835276%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67904457&oldid=1785269000"